ProCE Banner Activity


Obesity as a Cardiovascular Risk Factor: Assessment and Management


Obesity is an epidemic that has serious adverse effects on patients seen by cardiologists. The educational program “Obesity as a Cardiovascular Risk Factor: Assessment and Management” will inform cardiologists about the effects of obesity on CVD, HF, and dysrhythmias and the benefit of weight loss, the efficacy and safety of agents FDA-approved to manage obesity and provide guidelines for starting and intensifying obesity treatment through shared decision making with patients.

Welcome and Introduction
Obesity as a Disease That Affects Cardiovascular Risk
Assessing obesity: BMI, Waist Circumference, and Body Fat Distribution
Pharmacotherapy for Obesity: Mechanism of Action, Efficacy, Safety, and Route of Administration
Evidence-based Management of Obesity
Question and Answers 

Physicians: Maximum of 1.50 AMA PRA Category 1 Credits™

Physicians: Maximum of 1.50 Medical Knowledge MOC points

Released: December 14, 2022

Expiration: December 14, 2023



Jean-Pierre Després

Jean-Pierre Després, CQ, PhD, FAHA, FIAS

Professor, Department of Kinesiology, Faculty of Medicine
Scientific Director, International Chair on Cardiometabolic Risk
Université Laval
Scientific Director
VITAM – Research Centre for Sustainable Health
Québec (Québec) Canada

Ian Neeland

Ian Neeland, MD, FAHA, FACC

Director, UH Center for Cardiovascular Prevention
Director, Translational Science Unit
Co-Director, Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA)
Harrington Heart and Vascular Institute
University Hospitals Cleveland Medical Center
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Cleveland, OH

Fatima Cody Stanford

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

Associate Professor of Medicine and Pediatrics
Harvard Medical School
Obesity Medicine Physician-Scientist
Neuroendocrine Unit, Pediatric Endocrinology, MGH Weight Center   
Equity Director, Endocrine Division, Department of Medicine
Director of Diversity
Nutrition Obesity Research Center at Harvard (NORCH)
Director, Anti-Racism Initiatives
Massachusetts General Hospital Neuroendocrine Unit
Core Faculty
Mongan Institute Disparities Solutions and Health Policy Research Centers
Leadership Team Massachusetts General Hospital Midlife Women’s Health Center
Boston, MA

Provided by

Jointly provided by the Potomac Center for Medical Education and Rockpointe 

ProCE Banner
ProCE Banner


Supported by an educational grant from Novo Nordisk.

Novo Nordisk

Target Audience

The intended audience for this educational initiative is cardiologists, who are clinicians that manage patients with obesity and cardiovascular disease.

Learning Objectives

At the conclusion of this education, participants should be able to:

  • Characterize the physiologic effects of obesity and its comorbidities on the cardiovascular system

  • Discuss the cardiovascular advantages of managing obesity

  • Describe the efficacy and safety data for agents approved for the management of obesity and those in late-stage development

  • Develop evidence-based personalized management plans for obesity in concert with the patient using shared decision making


Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other relevant professional organizations, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of an accredited continuing education program provided by the Potomac Center for Medical Education are required to disclose to PCME all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by PCME in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by PCME to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by PCME.

Faculty, Authors, and Content Developers
The faculty, authors, and content developers reported the following relevant financial relationships with ineligible companies:

Jean-Pierre Després, CQ, PhD, FAHA, FIAS: Consulting Fee: Inversago Pharma Inc.

Ian J. Neeland, MD, FAHA, FACC: Advisory Board: Bayer Pharmaceuticals, Boehringer Ingelheim, Merck & Co; Honoraria: Cardiovascular Innovations, Nestle Health Sciences; Speakers' Bureau: Bayer Pharmaceuticals, Boehringer Ingelheim/Lilly Alliance

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS: Consulting Fee: Alfie, Boehringer Ingelheim, Calibrate, Coral Health, Currax, Eli Lilly, Gelesis, GoodRx, Lifeforce, Novo Nordisk, Pfizer, Veri; Contract Research: Amazon; Speakers' Bureau: Rhythm

Planners and Managers
The planners and managers reported the following relevant financial relationships with ineligible companies: 

Terry Glauser, MD: Has no relevant financial relationships

Content Reviewers
The content reviewers reported the following relevant financial relationships with ineligible companies: 

Katie Propst, PhD: Has no relevant financial relationships

Instructions for Credit

There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME/MOC/MIPS activity in its entirety, and then complete the post-test, with a score of 70 or better, and evaluation. The estimated time for completion of this activity is 1.5 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.

Disclosure of Unlabeled Use

The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Potomac Center for Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME/MOC credit or the evaluation, please email


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To recieve CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory,Obesity as a Cardiovascular Risk Factor: Assessment and Management has met the requirements as a Lifelong Learning CME Activity(apply toward general CME requirement) for the following ABMS Member Boards:

ABMS Lifelong Learning CME Activity
Family Medicine
Preventive Medicine
Psychiatry and Neurology

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

In order to fulfill requirements for MIPS improvement activity, participants will need to fill out 2 brief follow-up surveys at 30- and 90-days post-activity.